Woodline Partners’s Epizyme, Inc EPZM Stock Holding History

Woodline Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,866,148	Closed	-$5.68M	–	965
2022 Q2	$5.68M	Buy	3,866,148 +2,366,148	+158%	+$1.74M	0.09%	243
2022 Q1	$1.73M	Buy	+1,500,000	New	+$2.45M	0.03%	402
2021 Q3	–	Sell	-405,353	Closed	-$3.37M	–	780
2021 Q2	$3.37M	Buy	+405,353	New	+$3.42M	0.06%	281

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Woodline Partners's EPZM Position: Q3 2022 in Review

Woodline Partners sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 3,866,148 shares — an estimated $5.68M sold.

Woodline Partners first reported a position in EPZM in Q2 2021 and held it in 3 quarters. The position peaked at $5.68M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Woodline Partners reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Woodline Partners sold 3,866,148 Epizyme, Inc shares in Q3 2022, an estimated $5.68M.
Woodline Partners first reported a position in Epizyme, Inc in Q2 2021 and held it in 3 quarters.
Woodline Partners's Epizyme, Inc position peaked at $5.68M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.